Pamela Wapnick

This profile gathers the share dealings of Pamela Wapnick in Metagenomi Therapeutics, Inc. Between 1 April 2024 and 8 September 2026, the trades on record add up to 12 filings.

Sales make up the whole of the open-market record (8 sales, €34k). Other entries cover 4 share grants. In 2026 alone, the filings show no purchases and 2 sales.

The record was last updated on 10 September 2026 with an open-market sale (€1,903) in Metagenomi Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.